Clinical Trials Directory

Trials / Completed

CompletedNCT06548464

Interpretable Machine Learning Models for Prognosis in Gastric Cancer Patients

Development and Validation of Interpretable Machine Learning Models for Prognosis in Gastric Cancer Patients: a Multicenter Retrospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
18,000 (actual)
Sponsor
Chang-Ming Huang, Prof. · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This multicenter, retrospective cohort study aimed to develop and validate an explainable prediction model for prognosis after gastrectomy in patients with gastric cancer.

Detailed description

This multicenter, retrospective cohort study aimed to develop and validate an explainable prediction model for prognosis after gastrectomy in patients with gastric cancer. The study included patients who underwent radical gastrectomy for primary gastric or gastroesophageal junction cancer across multiple institutions in China. The primary objective was to create a machine learning-based model to predict postoperative outcomes following gastrectomy, using readily available clinical and pathological parameters. The main outcome of interest was early recurrence within 2 years after surgery, which significantly impacts overall prognosis. The study employed various machine learning algorithms to develop prediction models, which were then compared and validated. Model performance was assessed through measures such as area under the receiver operating characteristic curve (AUC), calibration, and Brier score. The SHapley Additive exPlanations (SHAP) method was used to interpret the model and rank feature importance. This research aims to provide clinicians with a tool for identifying patients at higher risk of poor postoperative outcomes who may benefit from more intensive post-operative monitoring and early intervention strategies, potentially improving prognosis for gastric cancer patients.

Conditions

Timeline

Start date
2024-06-01
Primary completion
2024-08-01
Completion
2024-08-06
First posted
2024-08-12
Last updated
2024-08-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06548464. Inclusion in this directory is not an endorsement.